Cyclic AMP (cAMP), the prototypical second messenger, regulates a wide variety of cellular processes. In the nervous system, cAMP has a role in many of the medium- to long-term changes that occur in neurons, and that we associate with higher-order functions such as learning and memory. However, it is unclear how one messenger is able to differentially regulate more than 200 cellular targets in response to a large diversity of extracellular stimuli. Until recently methods have not been available to unravel the spatial and temporal complexity of cAMP signals. The long term goals of this project are to measure cAMP signals in neurons and other excitable cells with high spatial and temporal resolution, to elucidate the cellular mechanisms underlying cAMP compartmentation, and to understand how cAMP signals are interpreted by downstream effectors. Several years ago we developed a series of genetically-engineered CNG ion channels as sensors for cAMP near the surface membrane. These channels are opened by the direct binding of cAMP, and allow cations to flow across the membrane. The approach has greater spatial and temporal resolution than other methods for measuring cAMP, and allowed, for the first time, the measurement of distinct cAMP signals within different compartments of non-excitable cells. We now propose to extend this method to excitable cell lines and primary cultured neurons.
Aim 1. To understand the molecular events that underlie large and transient cAMP signals near the membrane in excitable pituitary GH4C1 cells.
Aim 2. To measure membrane-localized cAMP signals in primary cultured neurons from the rat hippocampus, a brain region known to be important for memory formation.

Public Health Relevance

Cyclic AMP, because of its central role in signaling in the nervous system, is involved in the pathophysiology of many neurological disorders including memory loss, mood disorders, schizophrenia, and Parkinson's Disease. Unraveling the nature of cAMP signals in neurons should greatly enhance our understanding of these complex and debilitating diseases, and lead to improved therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH071625-01A2
Application #
7652631
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Asanuma, Chiiko
Project Start
2009-05-05
Project End
2011-04-30
Budget Start
2009-05-05
Budget End
2010-04-30
Support Year
1
Fiscal Year
2009
Total Cost
$346,500
Indirect Cost
Name
Oregon Health and Science University
Department
Physiology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Kirk, Sarah R; Andrade, Adriana L; Melich, Kenneth et al. (2011) Halogen substituents on the aromatic moiety of the tetracaine scaffold improve potency of cyclic nucleotide-gated channel block. Bioorg Med Chem Lett 21:6417-9
Andrade, Adriana L; Melich, Kenneth; Whatley, G Gregory et al. (2011) Cyclic nucleotide-gated channel block by hydrolysis-resistant tetracaine derivatives. J Med Chem 54:4904-12